EGFR and non-small cell lung carcinoma: As a consequence, the EGFR family has been targeted by many antibodies for therapeutic purpose, as many of them were approved to treat different cancer types (i.e., breast, colorectal, and non-small cells lung carcinoma (NSCLC), among others) [2].